Glioma Pathogenesis-Related Protein 1: Tumor-Suppressor Activities and Therapeutic Potential

od Thompson, Timothy C.
Izdano 2010

Grappling with the androgen receptor—a new approach for treating advanced prostate cancer

od Thompson, Timothy C.
Izdano 2010

Novel Regulation of Type IV Collagenase (Matrix Metalloproteinase-9 and -2) Activities by Transforming Growth Factor-β1 in Human Prostate Cancer Cell Lines

od Sehgal, Inder, Thompson, Timothy C.
Izdano 1999

Perifosine induces differentiation and cell death in prostate cancer cells

od Floryk, Daniel, Thompson, Timothy C.
Izdano 2008

Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells

od Floryk, Daniel, Thompson, Timothy C.
Izdano 2008

GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancer

od Karantanos, Theodoros, Thompson, Timothy C.
Izdano 2013

New targets for resistant prostate cancer

od Thompson, Timothy C., Li, Likun
Izdano u Oncotarget (2014)

Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer

od Thompson, Timothy C., Li, Likun
Izdano u Mol Cell Oncol (2017)

Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit

od Corn, Paul G, Thompson, Timothy C
Izdano 2010

N-MYC regulation of DNA damage response in neuroendocrine prostate cancer: mechanistic insight and novel combination therapy approaches

od Thompson, Timothy C., Liu, Bo, Li, Likun
Izdano u Oncoscience (2018)

Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells

od Tahir, Salahaldin A., Park, Sanghee, Thompson, Timothy C.
Izdano 2009

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate-resistance and novel therapeutic approaches

od Karantanos, Theodoros, Corn, Paul G., Thompson, Timothy C.
Izdano 2013

Combining enzalutamide with PARP inhibitors: Pharmaceutically induced BRCAness

od Thompson, Timothy C., Li, Likun, Broom, Bradley M.
Izdano u Oncotarget (2017)

Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistance

od Karanika, Styliani, Karantanos, Theodoros, Yin, Jianhua, Li, Likun, Thompson, Timothy C.
Izdano u Asian J Urol (2014)

DNA damage response and prostate cancer: defects, regulation and therapeutic implications

od Karanika, Styliani, Karantanos, Theodoros, Li, Likun, Corn, Paul G., Thompson, Timothy C.
Izdano u Oncogene (2014)

Caveolin-1 Maintains Activated Akt in Prostate Cancer Cells through Scaffolding Domain Binding Site Interactions with and Inhibition of Serine/Threonine Protein Phosphatases PP1 an...

od Li, Likun, Ren, Cheng Hui, Tahir, Salahaldin A., Ren, Chengzhen, Thompson, Timothy C.
Izdano 2003

“Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level”

od Karantanos, Theodoros, Evans, Christopher, Tombal, Bertrand, Thompson, Timothy C., Montironi, Rodolfo, Isaacs, William B.
Izdano u Eur Urol (2014)

Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models

od Tahir, Salahaldin A., Kurosaka, Shinji, Tanimoto, Ryuta, Goltsov, Alexei A., Park, Sanghee, Thompson, Timothy C.
Izdano 2013

Caveolin-1 Promotes Autoregulatory, Akt-mediated Induction of Cancer-Promoting Growth Factors in Prostate Cancer Cells

od Li, Likun, Ren, Chengzhen, Yang, Guang, Goltsov, Alexei A., Tabata, Ken-ichi, Thompson, Timothy C.
Izdano 2009

Castration-Induced Changes in Mouse Epididymal White Adipose Tissue

od Floryk, Daniel, Kurosaka, Shinji, Tanimoto, Ryuta, Yang, Guang, Goltsov, Alexei, Park, Sanghee, Thompson, Timothy C.
Izdano 2011